Preface: New River Pharmaceuticals Inc. NRPH of Virginia, the United States is founder and producer of the wonder drug for treatment of ADHD which designates Attention Deficit Hyperactivity Disorder, which is defined as childhood psychiatric disorder commonly found in children. The disease is rising at an alarming pace and the American scientists and different pharmaceutical formulators are extensively studying and taking up thorough researches for its fastest remedial drugs.

NRP104: New River Pharmaceuticals Inc. of the United States is launching the wonder formula for the treatment of such disorder, which is designated as “NRP 104”. The most advanced compound of NRP 104 is the Conditionally Bio-reversible Derivative - CBD of Amphetamine which is the clinically tested and proved as the most significant stimulant that is extensively used for the treatment of the ADHD patients in the United States.

NRP104 is the Amphetamine fused to the particular Amino Acid. NRP 104 is being specifically designed and developed for offering improved safeguard against overdose and simultaneously decreased possibility of craving than the Amphetamine preparations that are available in the market nowadays for efficient treatment of ADHD symptoms if properly taken under prescribed medical recommendations. The company also states that NRP 104 would reduce the possibility of the mistreatment to the patient or even the threat of drug distraction.

If someone reports inadequate levels of certain chemical transmitters in the brain which usually maintain motor control, attention, organization, further planning and decision making state is considered as ADHD disorder. Such transmitters could be enhanced through proper medication which results in remarkable academic and behavioral improvements.